If you listen to the BOA webcast, Gold noted that the current IMPACT study (blinded) had the highest MS (21.4 mos.) when using the Halabi nomogram compared with 9901 and 9902a. This suggests that this patient population may be the "fittest" in terms of prostate cancer survival. Thus, we may have to wait longer (late 2008 or 2009) until the 164th cancer death occurs before an interm analysis can be performed.
Market Data 
Markets 
AI
